OIG - Office of Inspector General
06/10/2026 | Press release | Distributed by Public on 06/11/2026 05:49
Ahold Delhaize USA Inc. to Pay $40M for Allegedly Reporting Inflated Drug Prices on Claims to Federal Healthcare Programs
Ahold Delhaize USA Inc. to Pay $40M for Allegedly Reporting Inflated Drug Prices on Claims to Federal Healthcare Programs
Ahold Delhaize USA Inc. (Ahold Delhaize), headquartered in Quincy, Massachusetts, has agreed to pay the United States and participating states a total of $40 million to resolve allegations that it violated the False Claims Act and state analogs by reporting inflated "usual and customary" prices on claims to federal healthcare programs.
Read more on https://www.justice.gov
Action Details
- Date:June 10, 2026
- Agency:U.S. Department of Justice
-
Enforcement Types:
- Criminal and Civil Actions
OIG - Office of Inspector General published this content on June 10, 2026, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on June 11, 2026 at 11:49 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]